Results

Total Results: 951 records

Showing results for "death".

41. Back (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/back.pdf
    January 01, 2011 - patients and  families wrestling with complex medical   decisions, finding a way to  approach  death … www.effectivehealthcare.ahrq.gov/index.cfm) � o Therapy to prepare for death

42. Cystic-Fibrosis-Hgh Surveillance (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cystic-fibrosis-hgh_surveillance.pdf
    August 01, 2012 - Hyperglycemia and death in cystic fibrosis- related diabetes. … (adjusted HR 4.05, 1.15, 14.28, p=0.03) or 3-year risk of death (unadj. … Death was associated with body mass index <19 (adjusted HR1.52, 95% CI 1.10, 2.10, p=0.011); use … Participation in registry Retrospective cohort study Risk factors associated with death in CF … Most common cause of death was CNS tumor (recurrence or new onset). 11% of deaths were judged

43. Jensen_ECCS2012 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/jensen_eccs2012.pdf
    January 01, 2012 - to manage patient communication Slide 9: Future Research Questions  and Courses  of Action • Death

44. Nonopioid Pharmacologic Treatments for Chronic Pain: Appendix F2 (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/nonopioid-chronic-pain-apf2_0.xlsx
    January 01, 2018 - NR NR NR NR NR NR NR NR Clegg, 2006 Good OA (knee) NSAID Celecoxib 200 mg/d 24 Short 7 318 NR NR CV death … NR NR NR NR NR NR NR NR NR NR Clegg, 2006 Good OA (knee) Placebo Placebo 24 Short 11 313 NR NR CV death … NR NR NR NR NR NR Silverstein, 2000 Good Mixed Diclofenac 150 mg/d 26 Intermediate NR NR NR NR CV death … NR NR NR NR NR NR Silverstein, 2000 Good Mixed Ibuprofen 2400 mg/d 26 Intermediate NR NR NR NR CV death … NR NR NR Nissen, 2016 Fair Mixed Celecoxib 200 to 400 mg/d (mean 209 mg/d) 80 Long NR NR NR NR CV death

45. Coronary-Artery-Stenting Executive (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/coronary-artery-stenting_executive.pdf
    February 01, 2013 - There were no incidences of in-hospital complications of coronary artery bypass grafting (CABG) or death … The FFR group also displayed a significant decrease in the composite outcome of death and MI at both … For the composite outcome of MACE (defined as death, MI, and target lesion revascularization) in this … which coronary lesions require intervention would confer a lower risk of the combined endpoint of death … The 1-year composite outcome of death, MI, and ischemia-driven target vessel revascularization was not

46. DEcIDE 33: Summary Variables in Observational Resesarch: Propensity Scores and Disease Risk Scores (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/observational-research-scores_research.pdf
    May 01, 2012 - Antipsychotic Use and Risk of Sudden Cardiac Death by Cardiovascular Risk Score .................. … Antipsychotics and the risk of sudden cardiac death. Arch Gen Psychiatry 2001;58:1161-67. 24. … Antipsychotic use and risk of sudden cardiac death by cardiovascular risk score Cardiovascular Disease … Antipsychotics and the risk of sudden cardiac death. … Cyclic antidepressants and the risk of sudden cardiac death.

47. Lysosomal-Storage-Diseases-Therapies Research-Protocol (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/lysosomal-storage-diseases-therapies_research-protocol.pdf
    November 15, 2012 - Life expectancy is < 10 years, with cause of death most commonly due to obstructive airway disease, … Life expectancy ranges from 10-20 yrs, with cause of death usually due to heart disease, from valvular … Life expectancy is 40 - 50 yrs, with cause of death usually due to a decline in kidney function or to … Life expectancy is <1 yr, with cause of death usually from cardiorespiratory failure or respiratory … Life expectancy is variable, depending on severity and rate of disease progression, with cause of death

48. Renal-Artery-Stenosis Surveillance (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/renal-artery-stenosis_surveillance.pdf
    June 01, 2012 - In Revascularization + medical therapy versus medical therapy, the HR for death was 0.90 with 95% CI … The HR for overall death was 0.99 with 95% CI= 0.30, 3.24 b. … The HR for Primary end point or death was 0.81 with 95% CI= 0.42, 1.56 8 1 Signal 3. … medical therapy Death: HR= 0.90; 95% CI= 0.69, 1.18; p = 0.46 1 Signal Medical vs. … In other words the reduction in the risk of death has moved from 30% to 10%.

49. AHA Branded Light Template (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/ahrq_community_forum_webinar_sadwin.pdf
    January 01, 2011 - AHA Branded Light Template Partnering with Patients to Disseminate Research Products Lawrence Sadwin October, 13 2011 Partnering with Patients to Disseminate Research Products • Relationships with patient and consumer organizations create channels for disseminating results • Establishing trust…

50. Layout 1 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/preterm-birth-terbutaline-pump_executive.pdf
    September 01, 2011 - : Key Question 1: improve neonatal health outcomes, including bronchopulmonary dysplasia, neonatal death … , death within initial hospitalization, significant intraventricular hemorrhage (grade III/IV), necrotizing … , death within initial hospitalization, and maternal withdrawal due to adverse effects (Withdrawal-AE … the strength of evidence favoring the SQ terbutaline pump compared with oral tocolytics for neonatal death … Infant mortality statistics from the 2006 period linked birth/infant death data set.

51. Layout 1 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/prostate-cancer_executive.pdf
    February 01, 2008 - treatment is to target the men most likely to need intervention in order to prevent prostate cancer death … Six months of combination therapy reduced clinical failure, biochemical failure, or death from any cause … • Death within 30 days of RP is approximately 0.5% in Medicare recipients age 65 and over. … High • Higher Gleason histologic scores are associated with greater risk of prostate-cancer-related death … PSA level Medium • The risk of prostate cancer death and disease progression or recurrence is associated

52. Evidence-based Practice Center Systematic Review Protocol (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/angina-heart-attack-treatments_research-protocol.pdf
    December 11, 2012 - patients with UA/NSTEMI involve the elimination of ischemia and the prevention of adverse events (death … For the majority of patients who are at higher risk of recurrent ischemia, MI, or death, an early invasive … or MI.8-11 For the minority of patients at low or intermediate risk of recurrent ischemia, MI, or death … All-cause death 10 2. Cardiovascular disease-related death 3. Nonfatal MI 4. … o Cardiovascular-related death o Nonfatal myocardial infarction o Revascularization o Stroke o

53. The Role of Immunotherapy in the Treatment of Asthma--Evidence Summary (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-196-evidence-summary-immunotherapy-asthma.pdf
    March 01, 2018 - There was insufficient evidence to draw conclusions regarding the effect of SCIT on anaphylaxis or death … • Serious adverse events such as anaphylaxis and death were not reported in the included studies in … non-RCT20 1 case series21 1 case report22 N=792 55 cases Likely (Likelihood of causality) Death … case reports41-43 2 Certain 1 Likely (Likelihood of causality) Unable to draw conclusions Death … low, 1 medium, 1 high) Consistent Direct Precise Undetected SLIT does not increase the risk of death

54. Cer-242-Radiation-Therapy-Brain-Metastases-Evidence-Summary (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/cer-242-radiation-therapy-brain-metastases-evidence-summary.pdf
    June 01, 2021 - of brain metastases may have substantial prognostic implications by causing neurologic symptoms or death

55. Evidence-based Practice Center Systematic Review Protocol (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/ischemic-stroke-treatment_research-protocol.pdf
    February 19, 2010 - Technical Brief Definition and Prevalence of Ischemic Stroke Stroke is the third leading cause of death … , 43.6 deaths occurred due to stroke per 100,000 people in the Unites States, averaging out to one death … that at-risk patients view the consequences of experiencing an ischemic stroke as being worse than death … downstream brain region.13 If blood flow is not restored to the affected area, ischemia and eventual cell death … Compressed Mortality File: Underlying Cause of Death, 1979-2005.

56. Heart-Failure-Natriuretic-Peptide Executive (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/heart-failure-natriuretic-peptide_executive.pdf
    November 01, 2013 - The other mortality outcomes (i.e., cardiac and sudden cardiac death) demonstrated less convincing … Sudden cardiac death had increasing HRs across the quintiles of NT-proBNP and an adjusted HR = 1.9 ( … Multimarker strategy for the prediction of 31 days cardiac death in patients with acutely decompensated … Use of multiple biomarkers to improve the prediction of death from cardiovascular causes. … N-terminal pro- B-type natriuretic peptide is associated with sudden cardiac death risk: the Cardiovascular

57. Effective Health Care (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0136_07-21-2009.pdf
    January 01, 2009 - including sexual function), and patient satisfaction; for surgical procedures, risk of complication and death

58. CER 5 Renal Artery Stenosis NSD SJ Clean (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/renal-artery-stenosis_overview.pdf
    June 24, 2014 - respect to the rate of the composite primary end point or any of its individual components, including death

59. Willis_respondent_DuBenske_4 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/web-based_willis_respondent.pdf
    January 01, 2009 - • Death  panel  versus  informed  decision-­‐making   o No  one  wants  to  die  

60. Quantitative Synthesis: Chapter 2. Presenting Different Effects for Different Data Types (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/ehc-presentation-quantitative-synthesis-chapter-2.pdf
    February 01, 2018 - in meta-analyses - More likely to be consistent even with differing baseline risks - Values of “death … rather than an assessment of appropriateness - Preferred if switching from event and non- event (e.g. death … being reciprocal for events and non- events. ► Thus, if switching from event and non-event (e.g., from death